SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-14-008832
Filing Date
2014-12-10
Accepted
2014-12-10 07:34:32
Documents
3
Period of Report
2014-12-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k120514_soligenix.htm 8-K 28951
2 PRESS RELEASE f8k120514ex99i_soligenix.htm EX-99.1 16203
3 GRAPHIC image_001.jpg GRAPHIC 52368
  Complete submission text file 0001213900-14-008832.txt   118950
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 141276559
SIC: 2834 Pharmaceutical Preparations